SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5548)9/1/1998 11:12:00 AM
From: Vector1  Read Replies (2) | Respond to of 9719
 
Rman,
Hard to tell how much of an overreaction this is. If they are delayed beyond the 99-2000 season that is a major loss in value. In additon the rejection is a major screw up by the company which is supposed to have a quality management team. The stock could trade even lower. I would hold off for the time being and would consider selling today to created margin room.
v1



To: Rocketman who wrote (5548)9/1/1998 12:16:00 PM
From: Kushi Kullar  Read Replies (1) | Respond to of 9719
 
<<The company noted that one important issue that may delay re-filing beyond October is a potential FDA requirement for another trial to bridge from the manufacturing process used for the Phase 3 pivotal trial to the process planned for commercial production. >>

How significant is this issue?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News